The pharmaceutical and life sciences industry faces escalating cyber threats targeting intellectual property, clinical data, and patient information, costing billions and risking lives. Rapid adoption of cloud, IoT, and analytics has expanded attack surfaces and data complexity. Thales recommends identifying and classifying sensitive data, encrypting it at rest, in motion, and in use, and maintaining key ownership through BYOK or BYOE models. Centralized governance, automation, and zero-trust frameworks are essential for compliance with HIPAA, GDPR, and similar mandates. Thales also stresses IoT security with cryptographic device identities and continuous authentication for resilient, compliant operations.

Join for free to read